Quintiles Buys Targeted Molecular Diagnostics

Quintiles Transnational Corp., a provider of professional services to the healthcare market, has acquired Targeted Molecular Diagnostics, a Westmont, Ill.-based developer of biomarker technologies for oncology research. No financial terms were disclosed. Quintiles shareholders include 3i Group, Bain Capital, Temasek Holdings and TPG Capital.

DealsNorth AmericaUSBriefs